FI943618L - Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineina, joilla on LTB4-antagonistinen vaikutus - Google Patents
Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineina, joilla on LTB4-antagonistinen vaikutus Download PDFInfo
- Publication number
- FI943618L FI943618L FI943618A FI943618A FI943618L FI 943618 L FI943618 L FI 943618L FI 943618 A FI943618 A FI 943618A FI 943618 A FI943618 A FI 943618A FI 943618 L FI943618 L FI 943618L
- Authority
- FI
- Finland
- Prior art keywords
- drugs
- preparation
- antagonistic activity
- amidine derivatives
- novel amidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4203201A DE4203201A1 (de) | 1992-02-05 | 1992-02-05 | Neue amidinderivate, ihre herstellung und verwendung |
| DE4224289A DE4224289A1 (de) | 1992-07-23 | 1992-07-23 | Neue Amidinderivate, ihre Herstellung und Verwendung |
| DE4244241A DE4244241A1 (de) | 1992-12-24 | 1992-12-24 | Neue Verbindungen, ihre Herstellung und ihre Verwendung |
| PCT/EP1993/000070 WO1993016036A1 (fr) | 1992-02-05 | 1993-01-14 | Nouveaux derives de l'amidine, leur fabrication et leur application en tant que medicaments ayant un effet antagoniste a ltb4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI943618A7 FI943618A7 (fi) | 1994-08-04 |
| FI943618L true FI943618L (fi) | 1994-08-04 |
| FI943618A0 FI943618A0 (fi) | 1994-08-04 |
Family
ID=27203364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943618A FI943618A0 (fi) | 1992-02-05 | 1993-01-14 | Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineina, joilla on LTB4-antagonistinen vaikutus |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US6037377A (fr) |
| EP (2) | EP0625138B1 (fr) |
| JP (2) | JP3487851B2 (fr) |
| KR (1) | KR0163222B1 (fr) |
| AT (2) | ATE180770T1 (fr) |
| AU (1) | AU673343B2 (fr) |
| CA (2) | CA2129526A1 (fr) |
| CZ (2) | CZ287209B6 (fr) |
| DE (2) | DE59310252D1 (fr) |
| DK (2) | DK0902013T3 (fr) |
| ES (2) | ES2165122T3 (fr) |
| FI (1) | FI943618A0 (fr) |
| GR (1) | GR3030468T3 (fr) |
| HR (1) | HRP930102B1 (fr) |
| HU (1) | HU216191B (fr) |
| IL (1) | IL104589A0 (fr) |
| MX (1) | MX9300630A (fr) |
| NO (1) | NO301540B1 (fr) |
| NZ (1) | NZ246593A (fr) |
| PL (2) | PL173781B1 (fr) |
| PT (1) | PT902013E (fr) |
| RU (1) | RU2124002C1 (fr) |
| SG (1) | SG44837A1 (fr) |
| SI (1) | SI9300066B (fr) |
| SK (1) | SK281016B6 (fr) |
| TW (1) | TW232005B (fr) |
| UA (1) | UA43318C2 (fr) |
| WO (1) | WO1993016036A1 (fr) |
| YU (1) | YU49038B (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5488160A (en) * | 1991-06-11 | 1996-01-30 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and method of treatment |
| US5451700A (en) * | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
| US5455274A (en) * | 1992-12-09 | 1995-10-03 | Ciba-Geigy Corporation | Hydroxyamidine derivatives |
| DE4309285A1 (de) * | 1993-03-23 | 1994-09-29 | Boehringer Ingelheim Kg | Heterocyclen enthaltende Amidinderivate, ihre Herstellung und Verwendung |
| DE4424714A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff |
| DE4424713A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe |
| DE19546452A1 (de) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel |
| CZ206698A3 (cs) | 1995-12-29 | 1998-11-11 | 3- Dimensional Pharmaceuticals, Inc. | Amidinové inhibitory proteas |
| US5942544A (en) * | 1996-02-22 | 1999-08-24 | Dupont Pharmaceuticals Company | α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors |
| DE19636689A1 (de) * | 1996-09-10 | 1998-03-12 | Boehringer Ingelheim Kg | Neue Benzamidinderivate |
| DE19637123A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Ingelheim Kg | Neue Pyranosidderivate |
| WO1998013347A1 (fr) * | 1996-09-26 | 1998-04-02 | Novartis Ag | Acrylamides substitues par de l'aryle ayant une activite antagoniste du recepteur leucotriene b4 (ltb-4) |
| US6670398B2 (en) * | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| CZ301985B6 (cs) | 1997-05-14 | 2010-08-25 | Atherogenics, Inc. | Lécivo pro lécení kardiovaskulárního onemocnení na bázi monoesteru probukolu s jantarovou kyselinou |
| US5872122A (en) * | 1997-10-16 | 1999-02-16 | Monsanto Company | Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation |
| ID24720A (id) | 1997-12-12 | 2000-08-03 | Novartis Ag | Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis |
| CN1283115A (zh) * | 1997-12-23 | 2001-02-07 | 先灵公司 | 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物 |
| US6291514B1 (en) | 1998-02-09 | 2001-09-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
| DE19948428A1 (de) * | 1999-10-07 | 2001-04-12 | Boehringer Ingelheim Pharma | Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel |
| FR2801053B1 (fr) * | 1999-11-16 | 2004-06-25 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments |
| DE10052333A1 (de) * | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Sulfooxybenzamide |
| US6528491B2 (en) * | 2000-10-24 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Pyranoside derivatives |
| AU2002320025A1 (en) * | 2001-04-11 | 2002-11-11 | Atherogenics, Inc. | Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality |
| US20030119901A1 (en) * | 2001-07-14 | 2003-06-26 | Boehringer Ingelheim Pharma Kg | Pharmaceutical formulation containing an LTB4 antagonist |
| PL368613A1 (en) * | 2001-07-14 | 2005-04-04 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Pharmaceutical formulation containing an ltb4 antagonist |
| US20040006092A1 (en) * | 2001-08-31 | 2004-01-08 | Neurochem, Inc. | Amidine derivatives for treating amyloidosis |
| US20060229335A1 (en) * | 2002-12-24 | 2006-10-12 | Bradley Teegarden | Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| EP1493739A1 (fr) * | 2003-07-03 | 2005-01-05 | Warner-Lambert Company LLC | Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| US7262223B2 (en) | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
| ES2333739T3 (es) * | 2004-11-23 | 2010-02-26 | Dong Wha Pharmaceutical Co., Ltd. | Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico. |
| GB2445920A (en) * | 2007-01-25 | 2008-07-30 | Mucokinetica Ltd | Amidino compounds for treatment of respiratory disease |
| WO2008118948A1 (fr) * | 2007-03-26 | 2008-10-02 | Atherogenics, Inc. | Procédés et compositions de dérivés de probucol pour le traitement du diabète |
| US20080280985A1 (en) * | 2007-03-27 | 2008-11-13 | Scott Robert A D | Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
| WO2010068794A2 (fr) | 2008-12-10 | 2010-06-17 | The General Hospital Corporation | Inhibiteurs de hif et leurs applications |
| AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
| EP2961746B1 (fr) | 2013-02-28 | 2018-01-03 | Bristol-Myers Squibb Company | Dérivés de phénylpyrazole en tant que puissants inhibiteurs de rock1 et rock2 |
| CA3121202A1 (fr) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Composes pyrrole et pyrazole et leurs procedes d'utilisation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2516922A1 (fr) * | 1981-11-25 | 1983-05-27 | Lipha | Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant |
| JPS62142168A (ja) * | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| SU1591809A3 (ru) * | 1987-09-16 | 1990-09-07 | Pfizer | Способ получения производных 4-гвдрокси-2-замещенного хроман-4-уксусной кислоты в виде рацемического соединения или оптически активного соединения или их фар |
| AU626033B2 (en) * | 1988-10-25 | 1992-07-23 | Government Of The United States Of America, As Represented By The Secretary Of The Army, The | Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods |
| US5246965A (en) * | 1991-06-11 | 1993-09-21 | Ciba-Geigy | Arylethers, their manufacture and methods of treatment |
| DE69203797T2 (de) * | 1991-06-11 | 1996-02-08 | Ciba Geigy Ag | Amidino-Verbindungen, ihre Herstellung und Verwendung als Arzneimittel. |
| EP0518818A3 (en) * | 1991-06-11 | 1993-04-28 | Ciba-Geigy Ag | Arylethers, their manufacture and use as medicament |
| US5424334A (en) * | 1991-12-19 | 1995-06-13 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
-
1993
- 1993-01-14 PL PL93316750A patent/PL173781B1/pl unknown
- 1993-01-14 EP EP93902195A patent/EP0625138B1/fr not_active Expired - Lifetime
- 1993-01-14 CA CA002129526A patent/CA2129526A1/fr not_active Abandoned
- 1993-01-14 WO PCT/EP1993/000070 patent/WO1993016036A1/fr not_active Ceased
- 1993-01-14 SK SK914-94A patent/SK281016B6/sk unknown
- 1993-01-14 UA UA94095773A patent/UA43318C2/uk unknown
- 1993-01-14 NZ NZ246593A patent/NZ246593A/en unknown
- 1993-01-14 ES ES98121305T patent/ES2165122T3/es not_active Expired - Lifetime
- 1993-01-14 DK DK98121305T patent/DK0902013T3/da active
- 1993-01-14 KR KR1019940702669A patent/KR0163222B1/ko not_active Expired - Fee Related
- 1993-01-14 HU HU9402291A patent/HU216191B/hu not_active IP Right Cessation
- 1993-01-14 DK DK93902195T patent/DK0625138T3/da active
- 1993-01-14 JP JP51370193A patent/JP3487851B2/ja not_active Expired - Fee Related
- 1993-01-14 DE DE59310252T patent/DE59310252D1/de not_active Expired - Fee Related
- 1993-01-14 ES ES93902195T patent/ES2132216T3/es not_active Expired - Lifetime
- 1993-01-14 PT PT98121305T patent/PT902013E/pt unknown
- 1993-01-14 RU RU94041836A patent/RU2124002C1/ru not_active IP Right Cessation
- 1993-01-14 AU AU33497/93A patent/AU673343B2/en not_active Ceased
- 1993-01-14 AT AT93902195T patent/ATE180770T1/de not_active IP Right Cessation
- 1993-01-14 CZ CZ19941886A patent/CZ287209B6/cs unknown
- 1993-01-14 FI FI943618A patent/FI943618A0/fi unknown
- 1993-01-14 EP EP98121305A patent/EP0902013B1/fr not_active Expired - Lifetime
- 1993-01-14 SG SG1996008431A patent/SG44837A1/en unknown
- 1993-01-14 DE DE59309630T patent/DE59309630D1/de not_active Expired - Fee Related
- 1993-01-14 PL PL93304713A patent/PL173789B1/pl unknown
- 1993-01-14 CA CA002427890A patent/CA2427890A1/fr not_active Abandoned
- 1993-01-14 AT AT98121305T patent/ATE210634T1/de not_active IP Right Cessation
- 1993-01-29 TW TW082100562A patent/TW232005B/zh active
- 1993-02-03 HR HRP4244241.9A patent/HRP930102B1/xx not_active IP Right Cessation
- 1993-02-03 YU YU6393A patent/YU49038B/sh unknown
- 1993-02-03 IL IL104589A patent/IL104589A0/xx not_active IP Right Cessation
- 1993-02-04 MX MX9300630A patent/MX9300630A/es not_active IP Right Cessation
- 1993-02-05 SI SI9300066A patent/SI9300066B/sl not_active IP Right Cessation
-
1994
- 1994-08-04 NO NO942903A patent/NO301540B1/no not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/460,961 patent/US6037377A/en not_active Expired - Lifetime
-
1997
- 1997-04-18 CZ CZ19971203A patent/CZ287173B6/cs unknown
-
1999
- 1999-06-09 GR GR990401541T patent/GR3030468T3/el unknown
-
2000
- 2000-01-18 US US09/484,073 patent/US6489365B1/en not_active Expired - Lifetime
-
2002
- 2002-03-18 JP JP2002073593A patent/JP2002322143A/ja active Pending
- 2002-09-23 US US10/252,976 patent/US20030130232A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI943618L (fi) | Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineina, joilla on LTB4-antagonistinen vaikutus | |
| FI935897A7 (fi) | Pyridopyrimidiinijohdannaiset, niiden valmistus ja käyttö | |
| FI955248A7 (fi) | 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| NO910723D0 (no) | Karbapenemderivater med antibiotisk aktivitet, samt fremstilling og anvendelse derav. | |
| FI862029A7 (fi) | Askorbiinihappojohdannaiset, niiden valmistus ja käyttö. | |
| FI935887L (fi) | Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö | |
| FI955140L (fi) | Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä | |
| EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
| FI954491A7 (fi) | Heterosykliä sisältäviä amidiinijohdokset, niiden valmistus ja käyttö | |
| DE3677445D1 (de) | 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung. | |
| FI922983A7 (fi) | Pyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja terapeuttinen käyttö | |
| FI914611A7 (fi) | 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI941287A0 (fi) | Triatsolokinoksalin-1,4-dioneja ja niiden valmistus ja käyttö | |
| FI892344A7 (fi) | 6-fenyyli-3-piperatsinyylialkyyli-1H,3H-pyrimidiini-2,4-dionin johdannaisia, niiden valmistus ja niiden terapeuttinen käyttö | |
| FI922982A7 (fi) | 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö | |
| FI930716A7 (fi) | Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö | |
| FI861526A7 (fi) | Nitrofuraanin johdannaiset, niiden valmistus ja soveltaminen terapiassa. | |
| FI921814A7 (fi) | 2-aminopyrimidiini-4-karboksiamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI920663A7 (fi) | Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI950533L (fi) | Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä | |
| FI20002501L (fi) | Uudet amidiinijohdannaiset, niiden valmistus ja käyttö lääkeaineena, joilla on LTB4-antagonistinen vaikutus | |
| FI894758A7 (fi) | 3-Aryylioksimetyyli-kefalosporiinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö | |
| FI922980A7 (fi) | 2-piperidinyylipyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI896170A7 (fi) | Substituoituja guanidiini- ja amidiiniyhdisteitä sekä niiden valmistus ja fungisidinen käyttö | |
| BR1100515A (pt) | Derivados de amidina, sua preparação e utilização como medicamentos com ação antagonista de ltb4 |